1 Min Read
Oct 4 (Reuters) - Avita Medical Ltd
* U.S. FDA approves new continued access protocol for the Recell Device for treatment of burn injuries Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.